Shanrong Biotechnology Corp.
SRBT · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $47 | $235 | $69 | $179 |
| - Cash | $0 | $0 | $2 | $2 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $47 | $235 | $67 | $178 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$6 | -$5 | -$11 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$6 | -$5 | -$11 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.003 | -0.013 | -0.011 | -0.022 |
| % Growth | 77.2% | -15.5% | 50% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |